Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gemina Laboratories Ltd
(CSE:
GLAB
)
0.3950
UNCHANGED
Streaming Delayed Price
Updated: 2:04 PM EDT, Oct 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.3950
Bid (Size)
0.2850 (4,500)
Ask (Size)
0.3950 (2,000)
Prev. Close
0.3950
Today's Range
0.3950 - 0.3950
52wk Range
0.3200 - 1.250
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gemina Laboratories Announces Private Placement
November 13, 2024
Via
ACCESSWIRE
Gemina Laboratories Strategic Update
July 10, 2024
Via
ACCESSWIRE
Performance
YTD
-43.6%
-43.6%
1 Month
-17.7%
-17.7%
3 Month
-46.6%
-46.6%
6 Month
-62.4%
-62.4%
1 Year
-14.1%
-14.1%
More News
Read More
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
June 20, 2024
Via
ACCESSWIRE
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Labs Announces Addition to its IP Portfolio
April 09, 2024
Via
ACCESSWIRE
Gemina Labs to Present at the Life Science Investor Forum June 20th
June 17, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Laboratories Sign First Strategic License Agreement
April 02, 2024
Via
ACCESSWIRE
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
March 21, 2024
Via
ACCESSWIRE
Gemina Announces Closing of $910,000 Convertible Note Financing
March 19, 2024
Via
ACCESSWIRE
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
June 15, 2023
Via
ACCESSWIRE
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Via
ACCESSWIRE
ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
October 10, 2023
Via
Get News
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
July 25, 2023
Via
ACCESSWIRE
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
June 05, 2023
Via
ACCESSWIRE
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
May 17, 2023
Via
ACCESSWIRE
Gemina Laboratories to Host Investor Webinar on March 30, 2023
March 27, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
March 07, 2023
Via
ACCESSWIRE
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
January 25, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
January 23, 2023
Via
ACCESSWIRE
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
January 10, 2023
Via
ACCESSWIRE
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
January 06, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Via
ACCESSWIRE
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Via
ACCESSWIRE
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 07, 2022
Via
ACCESSWIRE
Frequently Asked Questions
Is Gemina Laboratories Ltd publicly traded?
Yes, Gemina Laboratories Ltd is publicly traded.
What exchange does Gemina Laboratories Ltd trade on?
Gemina Laboratories Ltd trades on the Canadian Securities Exchange
What is the ticker symbol for Gemina Laboratories Ltd?
The ticker symbol for Gemina Laboratories Ltd is GLAB on the Canadian Securities Exchange
What is the current price of Gemina Laboratories Ltd?
The current price of Gemina Laboratories Ltd is 0.3950
When was Gemina Laboratories Ltd last traded?
The last trade of Gemina Laboratories Ltd was at 10/29/25 02:04 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today